Search Within

Ross Levine

Formats
  1. Journal Article (386)
  2. Meeting Abstract (343)
  3. Editorial (14)
  4. Review (13)
  5. Research Letter (10)
  6. Book Section (3)
  7. Conference Paper (2)
  8. Guidelines (2)
  9. Book Whole (1)
Groups
  1. Adult Leukemia (774)
  2. Center for Hematologic Malignancies (774)
  3. Department of Medicine (774)
  4. Executive Committee, Center for Hematologic Malignancies (774)
  5. GSK Faculty (774)
  6. Hematologic Malignancies, Division of (774)

More Groups

People
  1. Omar Abdel-Wahab (166)
  2. Martin Tallman (131)
  3. Raajit Rampal (87)
  4. Eytan Stein (69)
  5. Maria Arcila (60)
  6. Jay Patel (52)

More People

Years
  1. 2025 (5)
  2. 2024 (32)
  3. 2023 (46)
  4. 2022 (41)
  5. 2021 (44)
  6. 2020 (58)

More Years

Publications
  1. Blood (289)
  2. Leukemia (34)
  3. Cancer Research (27)
  4. Haematologica (24)
  5. Blood Advances (21)
  6. Cancer Cell (21)

More Publications

Publishers
  1. American Society of Hematology (312)
  2. Nature Publishing Group (107)
  3. American Association for Cancer Research (67)
  4. Cell Press (47)
  5. Ferrata Storti Foundation (24)
  6. American Society of Clinical Oncology (22)

More Publishers

Results (774)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Arsenic trioxide therapy predisposes to herpes zoster reactivation despite minimally myelosuppressive therapy
    Journal Article

    Glass, J. L.; Derkach, A.; Hilden, P.; King, A.; Seo, S. K.; Ahr, K.; Kishtagari, A.; Levine, R. L.; Tallman, M. S.; Douer, D.
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • The role of somatic mutations in acute myeloid leukemia pathogenesis
    Review

    Kishtagari, A.; Levine, R. L.
    Cold Spring Harbor Perspectives in Medicine (2021)

    Fulltext@MSK | Save
  • Clinical and molecular predictors of response and survival following venetoclax therapy in relapsed/refractory AML
    Journal Article

    Stahl, M.; Menghrajani, K.; Derkach, A.; Chan, A.; Xiao, W.; Glass, J.; King, A. C.; Daniyan, A. F.; Famulare, C.; Cuello, B. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • The new science and concepts that underlie current and future treatments for myeloproliferative neoplasms
    Editorial

    Hoffman, R.; Levine, R.; Mascarenhas, J.; Rampal, R. K.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save
  • Epigenetic dysregulation of myeloproliferative neoplasms
    Review

    Dunbar, A.; Park, Y.; Levine, R.
    Hematology/Oncology Clinics of North America (2021)

    Fulltext@MSK | Save
  • The clinical implications of clonal hematopoiesis in hematopoietic cell transplantation
    Review

    Nawas, M. T.; Schetelig, J.; Damm, F.; Levine, R. L.; Perales, M. A.; Giralt, S. A.; VanDenBrink, M. R.; Arcila, M. E.; Zehir, A.; Papaemmanuil, E.; more...
    Blood Reviews (2021)

    Fulltext@MSK | Save
  • Smc3 dosage regulates B cell transit through germinal centers and restricts their malignant transformation
    Journal Article

    Rivas, M. A.; Meydan, C.; Chin, C. R.; Challman, M. F.; Kim, D.; Bhinder, B.; Kloetgen, A.; Viny, A. D.; Teater, M. R.; McNally, D. R.; more...
    Nature Immunology (2021)

    Fulltext@MSK | Save
  • Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
    Journal Article

    Gao, T.; Ptashkin, R.; Bolton, K. L.; Sirenko, M.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Characteristics and prognostic effects of IDH mutations across the age spectrum in AML: A collaborative analysis from COG, SWOG, and ECOG
    Meeting Abstract

    Zarnegar-Lumley, S.; Alonzo, T. A.; Othus, M.; Sun, Z.; Ries, R. E.; Wang, Y. C.; Leonti, A. R.; Kutny, M. A.; Stirewalt, D.; Radich, J. P.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Enasidenib (ENA) monotherapy with addition of azacitidine in non-responders is effective in older patients with newly diagnosed IDH2 mutated acute myeloid leukemia (AML): A completed phase 2/1b sub-study of the beat AML master trial
    Meeting Abstract

    Stein, E. M.; Huang, Y.; Borate, U.; Baer, M. R.; Stock, W.; Kovacsovics, T.; Blum, W.; Schiller, G. J.; Olin, R. L.; Foran, J. M.; more...
    Blood (2020)

    Fulltext@MSK | Save